During her post graduate studies with the research group of Ortiz de Montellano, she studied two families of heme proteins using varied techniques that included cloning, mutagenesis, and spectroscopy. Working with researchers at the University of California, Davis, she collaborated in the elucidation of the human HO-1 structures by NMR. She also prepared fusion proteins of human HO-1 with P450 reductase and with glutathione-S-transferase.[3]
In 2002, Auclair returned to McGill University to begin her teaching career as an assistant professor of chemistry.[1][3] She was named a full professor in 2016 and directs activities at the Auclair Laboratory.[1][3]
Memberships
Since 2023, she has served as a member of the Board of Directors at the French biochemistry company Carbios.[3]
Auclair, Karine; Sutherland, Andrew; Kennedy, Jonathan; Witter, David J.; Van den Heever, Johan P.; Hutchinson, C. Richard; Vederas, John C. (22 November 2000). "Lovastatin Nonaketide Synthase Catalyzes an Intramolecular Diels−Alder Reaction of a Substrate Analogue". Journal of the American Chemical Society. 122 (46): 11519–11520. doi:10.1021/ja003216+.
Auclair, Karine; Hu, Zhengbo; Little, Dorothy M.; Ortiz de Montellano, Paul R.; Groves, John T. (May 2002). "Revisiting the Mechanism of P450 Enzymes with the Radical Clocks Norcarane and Spiro[2,5]octane". Journal of the American Chemical Society. 124 (21): 6020–6027. doi:10.1021/ja025608h. PMID12022835.
References
^ abcdef"Karine Auclair". Department of Chemistry. McGill University. Retrieved 4 April 2021.
^"Tier 1 Canada Research Chairs". Office of the Provost and Vice-Principal (Academic). McGill University. Retrieved 4 April 2021.